TEPTOLZA, created in 2015 (United States), from 6 sister brands and 2214 competing brands. TEPTOLZA is owned by Nektar Therapeutics, listed on the stock exchange of New York The sector of TEPTOLZA is Biotechnology.

TEPTOLZA is a brand of Nektar Therapeutics (NKTR) Share price

International deposit : 2015 Business sector Biotechnology

Share price and profitability of the share Nektar Therapeutics (TEPTOLZA)

Buy Nektar Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 1.24

Portfolio valuation
Nektar Therapeutics (TEPTOLZA) over 5 years* USD 0.05

Stock market history Nektar Therapeutics (TEPTOLZA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Nektar Therapeutics

See more brands of Nektar Therapeutics

Rival brands
TEPTOLZA

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS